Pharma Courses
6 July 2020

Job Openings for M.Pharm, M.Sc in Government of India funded project | 08 vacancies

6 July 2020
Vacancy for B.Pharm, D.Pharm under NHM

Applications from citizens of Meghalaya are urgently required for appointment on contractual basis for filling up the following post as given below.

Post : Assistant Storekeeper

6 July 2020
Job for Scientific Officer at National Centre for Biological Sciences

6 July 2020
Job for Pharmacy graduates in Development Regulatory Centers at Novartis

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Specialist, DRC (Development Regulatory Centers)

6 July 2020
Job for Manufacturing Chemist at Polymedicure Limited

POLYMED was conceived and established by a group of making the benefit of modern healthcare available to the mankind at affordable price. POLYMED's main strength is its fully committed, well trained and technically competent personnel.

6 July 2020
M.Pharm, M.Sc, B.Pharm Freshers Recruitment at Pulse Pharmaceuticals

Pulse is a fast-growing Pharmaceutical company with a vertically & diagonally integrated business model, focused on providing innovative product solutions to a large number of people around the world, to help them manage their health better & lead a quality life.

6 July 2020
Vacancy for Business Development Executive at Clinpro Research

ClinPro Research is an emerging service provider in the clinical trials space. It provides clinical trial related services to contract research organizations (CROs), pharmaceutical companies, biotechnology companies, medical device companies and/or clinical sites.

WHO accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir arms. The Solidarity Trial was established by WHO to find an effective COVID-19 treatment for hospitalized patients.

The International Steering Committee formulated the recommendation in light of the evidence for hydroxychloroquine vs standard-of-care and for lopinavir/ritonavir vs standard-of-care from the Solidarity trial interim results, and from a review of the evidence from all trials presented at the 1-2 July WHO Summit on COVID-19 research and innovation.

These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.


For each of the drugs, the interim results do not provide solid evidence of increased mortality. There were, however, some associated safety signals in the clinical laboratory findings of the add-on Discovery trial, a participant in the Solidarity trial. These will also be reported in the peer-reviewed publication.

This decision applies only to the conduct of the Solidarity trial in hospitalized patients and does not affect the possible evaluation in other studies of hydroxychloroquine or lopinavir/ritonavir in non-hospitalized patients or as pre- or post-exposure prophylaxis for COVID-19. The interim Solidarity results are now being readied for peer-reviewed publication.


<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email

Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.

The Agency is telling manufacturers and suppliers of thermal cameras that they should not make claims which directly relate to COVID-19 diagnosis, and is reminding businesses to follow Government advice on safe working during COVID-19.

Graeme Tunbridge, MHRA Director of Devices, said:
1. Many thermal cameras and temperature screening products were originally designed for non-medical purposes, such as for building or site security. Businesses and organisations need to know that using these products for temperature screening could put people’s health at risk.
2. These products should only be used in line with the manufacturer’s original intended use, and not to screen people for COVID-19 symptoms. They do not perform to the level required to accurately support a medical diagnosis.
3. We are reminding anyone selling these products not to make claims which directly relate to COVID-19 diagnosis. If they fail to comply, we will take formal enforcement action.

Products which the manufacturer claims are intended for screening for COVID-19, or fever-like symptoms, would be regarded as medical devices and regulated by the MHRA.


There is little scientific evidence to support temperature screening as a reliable method for detection of COVID-19 or other febrile illness, especially if used as the main method of testing.

Temperature readings from temperature screening systems will measure skin temperature rather than core body temperature. In either case, natural fluctuations in temperature can occur among healthy individuals. These readings are therefore an unreliable measure for detection of COVID-19 or other diseases which may cause fever. Furthermore, infected people who do not develop a fever or who do not show any symptoms would not be detected by a temperature reading and could be more likely to unknowingly spread the virus.


<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email

With the announcement of COVAXIN by Bharat Biotech and ZyCov-D Vaccine by Zydus Cadila the proverbial silver line in the dark clouds of COVID19 appears at the horizon. Now the nod given by the Drug Controller General of India CDSCO (The Central Drugs Standard Control Organisation) for the conduct of the human trial for the vaccines, marks the beginning of the end.

6 July 2020
International regulators provide guiding principles for COVID-19 clinical trials

EMA has endorsed a joint statement on prioritisation of COVID-19 clinical trials published by the International Coalition of Medicines Regulatory Authorities (ICMRA). Medicines regulators from around the world have jointly developed this statement to step up global collaboration to facilitate and expedite the development and evaluation of therapeutics, diagnostics and vaccines against COVID-19.

6 July 2020
FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer. This marks the first immunotherapy approved for this patient population as a first-line treatment and which is administered to patients without also giving chemotherapy.

5 July 2020
Job for Pharmacists (25 posts) due to COVID-19 outbreak - Government Jobs

Following the Spread of Covid-19 infectious disease for Ahmednagar district under National Health Mission, recruitment process for Covid-19 under Covid Hospitals in Ahmednagar district (ccc / DCHC / DCH) is as per the table given below.  These hospitals have been set up in Ahmednagar and Ahmednagar rural areas. 

5 July 2020
Pharmacists (12 Posts) vacancies under the administrative control of A.P. Vaidya Vidhana Parishad Hospital

5 July 2020
Career for M.Pharm as Associate Scientist at Syngene International

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities.

Post : Associate Scientist-Bioanalysis (11061)

5 July 2020
Job for Synthesis and Analytical R&D at GVK BIO

GVK BIO is a global Contract Research & Development Organization (CRDO) providing Drug Discovery and Development services to the biopharma industry. Established in 2001, GVK BIO for over 18 years has supported the Research and Development programs of innovator drug companies enabling them to bring their products to market quicker and cost- effectively.

5 July 2020
Multiple Vacancies in Pharmacovigilance at IQVIA

IQVIA™ is the leading human data science company focused on helping healthcare clients find unparalleled insights and better solutions for patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness the power of healthcare data, domain expertise, transformative technology, and advanced analytics to drive healthcare forward.

5 July 2020
Vacancy for MPharm, BPharm, MSc in Production at Sanofi

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

4 July 2020
Opportunity for M.Pharm, M.Sc in research at NIT | Government of India

NIT Rourkela is one of the premier national level institutions for technical education in the country and is funded by the Government of India. Government of India has elevated the Regional Engineering College, Rourkela to a deemed university under the name of National Institute of Technology, Rourkela.  The main objective of the Institute is to produce quality Engineers and Scientists in Graduate and Post-Graduate levels in various branches of Engineering and Science.

Subscribe to